INTRODUCTION
The structurally and functionally conserved target of rapamycin complex 1 (TORC1) plays a central role in the control of eukaryotic cell growth by promoting anabolic processes (e.g., protein synthesis) and inhibiting catabolic processes (e.g., autophagy) in response to a variety of signals, including hormones, growth factors, energy levels, and amino acids such as leucine (Avruch et al., 2009) . The mechanism through which leucine signals to TORC1 relies on the highly conserved Gtr1/RagA/B and Gtr2/ RagC/D Rag GTPases, which function in heterodimeric complexes containing one Gtr1-like and one Gtr2-like GTPase that are tethered, via the Ego1/3 subunits of the yeast EGO complex (EGOC) or the structurally related mammalian Ragulator complex, to the vacuolar or lysosomal membranes, respectively (Binda et al., 2009; Dubouloz et al., 2005; Kim et al., 2008; Kogan et al., 2010; Sancak et al., 2010; Sancak et al., 2008) . Via unknown mechanisms, leucine promotes the GTPbound state of Gtr1-like GTPases, which combine with GDPbound Gtr2-like GTPases to interact with and activate TORC1 (Binda et al., 2009; Kim et al., 2008; Sancak et al., 2008) . In mammalian cells, this involves Rag-Ragulator complex-dependent positioning of TORC1 in proximity to Rheb (Sancak et al., 2010; Sancak et al., 2008) . How leucine signals to Gtr1/RagA/ B to control TORC1, however, remains mysterious.
Here, we show that the leucyl-tRNA synthetase (LeuRS) Cdc60 interacts with the Rag GTPase Gtr1 of the EGOC in a leucine-dependent manner. This interaction, which is necessary and sufficient for TORC1 activation by leucine, is mediated by the nonessential amino acid-editing domain and does not require the functionally independent aminoacylation activity of Cdc60. We propose a simple model in which the conformational change adopted by the Cdc60 editing domain, which results from its engagement in editing mischarged tRNA Leu , disrupts the Cdc60-Gtr1 interaction and consequently causes downregulation of TORC1.
RESULTS AND DISCUSSION
LeuRS Cdc60 Physically Interacts with the TORC1 Regulator Gtr1 in a Leucine-Dependent Manner Based on both the observation that leucine is one of the most potent TORC1 activators (Avruch et al., 2009 ) and the assumption that proteins involved in signaling amino acid availability are likely to interact with Gtr1 in an amino acid-dependent manner, we purified Gtr1-TAP from yeast cells prior to and following leucine starvation and determined the coprecipitating proteins by mass spectrometry (MS). Remarkably, besides various proteins involved in fatty acid synthesis (e.g., Fas1, Faa4, and Acc1), we identified the LeuRS Cdc60 among the most prospective leucine-dependent, Gtr1-interacting candidate proteins (Table S1 available online) . This finding, which we independently confirmed in coprecipitation assays using an endogenously tagged version of Cdc60 ( Figures 1A, 1B , and S1), suggests that the LeuRS Cdc60 may play a role in signaling leucine availability to Gtr1-TORC1. Notably, eukaryotic LeuRSs exhibit two functionally separate activities, namely an essential tRNA Leu aminoacylation activity and an amino acid proofreading (editing) activity that involves recognition and hydrolysis of misacetylated tRNA Leu molecules (Ling et al., 2009) . To study whether LeuRS-mediated aminoacylation impinges on TORC1, we first used a temperature-sensitive (ts) cdc60 ts strain ( Figure 1C ) that is defective in tRNA Leu aminoacylation and, therefore, accumulates uncharged tRNA Leu at the restrictive temperature (Hohmann and Thevelein, 1992 Figure 1D ). Under the same conditions, however, temperature-inactivation of Cdc60 ts had no significant impact on TORC1 activity, as assessed by monitoring the phosphorylation level of the TORC1 substrate Sch9 ( Figure 1D ) (Urban et al., 2007) . These observations are consistent with similar experiments in Chinese hamster ovary cells , indicating that LeuRS-mediated aminoacylation, uncharged tRNAs, and Gcn2 kinase activation do not impinge on TORC1 regulation.
Trapping of tRNA Leu within the LeuRS Editing Site
Downregulates EGOC-TORC1 Signaling To study whether the editing function of LeuRS may be implicated in TORC1 control, we used 1,3-dihydro-1-hydroxy-2,1-benzoxaborole (DHBB), an analog of the antifungal compound 5-fluoro-DHBB (aka AN2690), which inhibits cell growth by trapping uncharged tRNA Leu in the editing active site within the connective peptide 1 (CP1) domain of LeuRS (Figure 2A ) (Rock et al., 2007) . Surprisingly, DHBB treatment, which did not noticeably alter Gtr1-GFP and Tor1-GFP localization ( Figures S2A and S2B ), resulted in significant downregulation of TORC1 activity in WT cells, but not in cells expressing the DHBB-resistant Cdc60 D418R variant (Rock et al., 2007; Yao et al., 2008) (Figures 2 and 2B ). In addition, coexpression of the Gtr1 GTP and Gtr2 GDP alleles, which are predicted to be restricted to a GTP-and GDP-bound conformation (Binda et al., 2009; Gao and Kaiser, 2006) , respectively, almost entirely suppressed the DHBB-mediated TORC1 inactivation without affecting the corresponding accumulation of uncharged tRNA Leu , the activation of Gcn2, or inhibition of growth in DHBB-treated cells (Figures, 2B, and 2C) . Moreover, DHBB disrupted, in a concentration-dependent manner, the Gtr1-Cdc60 (and Gtr1 GTP -Cdc60; Figure S2C ), but not the Gtr1-Cdc60 D418R interaction ( Figures 2D and 2E ).
To explore whether DHBB treatment affects the GTP-loading status of Gtr1, we made use of the fact that Gtr1 GTP -TAP, but not Gtr1 GDP -TAP, specifically coprecipitates with the TORC1 subunit Kog1 (Binda et al., 2009) ; hence, the level of Kog1-associated Gtr1 can be used to estimate the relative amount of Gtr1 GTP within cells. Using this assay, we found that DHBB treatment, like leucine starvation, severely reduced the interaction between Gtr1 and Kog1 ( Figure 2F ). Together, these data evoke a simple model in which the conformational change adopted by the CP1 domain in Cdc60, which results from its engagement in editing mischarged tRNA Leu (Tukalo et al., 2005) or from binding the DHBB-tRNA Leu adduct (D). Immunoblots detecting the extent of Sch9 phosphorylation were used to quantify in vivo TORC1 activity (Urban et al., 2007) in exponentially growing WT (cdc60 ts harboring a plasmid expressing CDC60) and cdc60 ts strains that were grown at the indicated temperatures (top); numbers below the blot refer to the mean ratio of hyperphosphorylated [+P]/hypophosphorylated [-P] Sch9 from three independent experiments, normalized to the values at time 0). Levels of eIF2a phosphorylation (on Ser 51 ) were used as a proxy for the accumulation of uncharged tRNA Leu (Hinnebusch, 2005) (lower panels; numbers below the blot refer to the mean ratio of phosphorylated eIF2a-P/unphosphorylated eIF2a from three independent experiments). (Rock et al., 2007) , disrupts the Cdc60-Gtr1 interaction and consequently causes GTP hydrolysis within Gtr1 and downregulation of TORC1. Notably, a catalytically defective cdc60 D419A editing mutant responds normally to leucine starvation in terms of TORC1 inactivation (Yao et al., 2008; Figure S3A) , indicating that the structural rearrangement of the CP1 domain, rather than the ensuing hydrolysis of mischarged tRNAs, primarily signals to EGOC-TORC1. Interestingly, the corresponding conformational change of the CP1 domain appears to depend on prior tRNA Leu aminoacylation/misacetylation because temperature-inactivation of Cdc60 ts significantly protects TORC1 from leucine starvation-induced downregulation ( Figure S3B ).
The LeuRS Inhibitors Leucinol and Norvaline Oppositely Affect EGOC-TORC1 Signaling
To further substantiate our model, we made use of two leucine analogs, namely leucinol (LeuOH) and norvaline (Nva), which both competitively inhibit LeuRS (and therefore growth) in different ways. LeuOH cannot be charged onto tRNA Leu (Rouget and Chapeville, 1968) and it blocks LeuRS-mediated aminoacylation (and growth; Figures 3A and 3B ), thus impeding LeuRS from engaging in editing activities. In contrast, Nva is both charged and edited by LeuRS (Ataide and Ibba, 2006; Chen et al., 2011) and, as a result, sustains a futile cycle of charging and editing, limiting growth at higher Nva concentrations (Figure 3B) . Consistent with our model and its mode of action toward (F) Gtr1-Kog1 interaction is sensitive to both DHBB treatment and leucine starvation. Cells expressing Gtr1-TAP and Kog1-HA 3 were harvested either in exponential growth phase or following a 30 min period of DHBB treatment or leucine starvation. See also Figure S2 .
LeuRS, LeuOH did not cause TORC1 downregulation ( Figure 3C ). Instead, and in line with similar observations in Xenopus laevis oocytes (Christie et al., 2002) , LeuOH was equally competent as leucine in activating TORC1 in leucine-starved WT, but not in gtr1D cells ( Figure 3D ; Binda et al., 2009 and data not shown). As expected, neither LeuOH nor leucine was able to restimulate TORC1 in the presence of DHBB ( Figure 3D ). The results with Nva were equally clear: Nva potently inhibited TORC1 in WT cells (without increasing the levels of uncharged tRNA Leu ; Figure 3A) even when applied in concentrations that are subinhibitory for growth ( Figures 3B and 3C ). Importantly, Nva-mediated downregulation of TORC1, but not the observed growth inhibition at higher Nva concentrations, was significantly suppressed by expression of the Gtr1 GTP /Gtr2 GDP -encoding alleles ( Figures   3B and 3C) . Together with the observations that 1) the addition of a disproportionate quantity of isoleucine causes transient TORC1 inactivation in WT cells (Figures S3C) and 2) LeuRS editing is specifically required for growth under leucine-limiting conditions ( Figure S3D ), these data corroborate a model in which tRNA Leu mischarging following leucine deprivation represents a key signal that impinges on EGOC-TORC1 signaling.
Mutation of Ser 414 to Phe within the CP1 Domain of Cdc60 Disrupts Its Interaction with Gtr1
Our model predicts that mutations within Cdc60, which prevent it from binding Gtr1, may uncouple LeuRS-signaling from LeuRS-tRNA Leu charging. Conceivably, corresponding Cdc60 variants may grant a yet elusive GTPase activating protein access to Gtr1, thus provoking downregulation of TORC1. Based on this reasoning, we tried to identify cdc60 alleles that confer rapamycin-sensitive growth by employing a classical plasmid-shuffling technique with a plasmid library of PCRmutagenized CDC60 genes (Forsburg, 2001 ). This approach allowed us to isolate the cdc60 S414F allele that, similar to gtr1D, caused no obvious growth defect per se, but rendered cells defective for growth in the presence of low doses of rapamycin ( Figure 4A ). Because the rapamycin-sensitivity of cdc60 S414F cells could be suppressed by expression of the Gtr1 GTP /Gtr2 GDP -encoding alleles ( Figure 4A ), we then used two-hybrid and coimmunoprecipitation (coIP) analyses to verify our assumption that the Cdc60 S414F variant may be defective in binding Gtr1. These experiments not only revealed that the CP1 editing domain within Cdc60 (CP1 Cdc60 ) specifically interacted with Gtr1 (and not with Gtr2; Figure 4B ), but also that the specific Ser 414 to Phe mutation within this domain abolished the CP1 Cdc60 -Gtr1 interaction ( Figures 4B and 4C ). Finally, in agreement with a model in which Cdc60 protects Gtr1 from a negative regulator, overproduction of CP1 Cdc60 , but not CP1 Cdc60-S414F , significantly protected TORC1 from inactivation during leucine starvation ( Figure 4D ).
In conclusion, LeuRS binds the TORC1-regulator Gtr1 via its CP1 editing domain, which is necessary and sufficient to mediate leucine signaling to TORC1. Notably, comprehensive analyses of amino acid composition in eukaryotic genomes revealed that leucine represents the most frequently used amino acid (Echols et al., 2002) , which, together with the fact that the LeuRS Cdc60 represents the most abundant aminoacyl-tRNA synthetase (Ghaemmaghami et al., 2003) , also provides a rationale for the preeminent effect of leucine in TORC1 regulation. Because TORC1 is deregulated in common cancers (Guertin and Sabatini, 2007) , it will be interesting to study whether the recently discovered contribution of human LeuRS (LARS1) to growth of human lung cancer cells (Shin et al., 2008 ) may also implicate Rag-Ragulator-complex-TORC1 signaling.
EXPERIMENTAL PROCEDURES
Strains, Growth Conditions, and Plasmids Unless stated otherwise, prototrophic strains were pre-grown overnight in synthetic medium without amino acids (SD; 0.17% yeast nitrogen base, 0.5% ammonium sulfate, and 2% glucose). Before each experiment, cells were diluted to an OD 600 of 0.2 in SD until they reached an OD 600 of 0.8. For leucine deprivation experiments, strains that were specifically auxotrophic for leucine were grown to an OD 600 of 0.8 on SD supplemented with leucine (0.37 mg ml -1 ), washed twice, and resuspended in SD. The S. cerevisiae strains and plasmids used in this study are listed in Tables S2 and S3 , respectively.
Extraction, Separation, and Analysis of Amino-Acylated tRNAs Assessment of tRNA leu charging was performed as described (Kö hrer and Rajbhandary, 2008) . Briefly, total RNA (from 10 OD 600 of cells) was extracted under acidic conditions (0.3 M NaOAc pH 4.5, 10 mM EDTA) in acetatesaturated phenol/chloroform. After quantification, 2 mg of total RNA were separated on a 6% denaturing acid/urea-acrylamide gel and, after transfer to a positively charged nylon membrane, were immobilized by UV-crosslinking. Hybridization was performed overnight at 42 C using P 32 -labeled oligonucleotide probes that specifically bind tRNA Leu (5 0 -GCATCTTACGATACCTG-3 0 )
or 5S rRNA (5 0 -GGTCACCCACTACACTACTCGG-3 0 ). The corresponding membranes were exposed at À80 C to X-ray films for autoradiography.
Tandem Affinity Purification (TAP) and IP Experiments Using a standard TAP-tag purification protocol (Gelperin et al., 2005) , Gtr1-TAP was purified from WT (YL515) cells harboring plasmid pMB1344-GTR1-TAP, which drives expression of Gtr1-TAP from its own promoter. Prior to protein extraction, cells were pre-grown on SD-URA and then washed and shifted for 30 min to SD-URA/-LEU. Gtr1-TAP preparations purified from cells prior and subsequent to leucine starvation were analyzed for coprecipitating partner proteins using MS/tandem MS analyses (Talarek et al., 2010) . CoIP experiments were essentially done as described (Dubouloz et al., 2005; Loewith et al., 2002) . Using IgG-coated sepharose beads, Gtr1-TAP and Igo1-TAP were purified from protein extracts that were prepared in lysis buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 5 mM MgCl 2 , 1 mM DTT) containing protease inhibitor cocktail (Roche) and 0.5 mM PMSF. After cleavage by TEV protease, eluates were further purified on calmodulin beads in lysis buffer with 2 mM CaCl 2 .
eIF2a and Sch9 Phosphorylation Analyses
For analysis of the phosphorylation status of eIF2a, cultures were mixed with TCA (final concentration 6%), put on ice for at least 5 min, pelleted, washed twice with cold acetone, and dried in a speed-vac. Cell lysis was done in 100 ml of urea buffer (50 mM Tris pH 7.5, 5 mM EDTA, 6 M urea, 1% SDS, 1 mM PMSF, and 0.5x PP i ) with glass beads in a bead beater, with subsequent heating for 10 min to 65 C. Equal amounts of total proteins from the different extracts were then resolved on 12% SDS-PAGE and subjected to immunoblotting using polyclonal antibodies specific for phosphorylated Ser 51 in S. cerevisiae eIF2a (Invitrogen). The blots were then stripped and reprobed with polyclonal anti-eIF2a antibodies. To analyze Sch9
T570A
-HA 5 C-terminal phosphorylation, we used the chemical fragmentation analysis as described previously (Urban et al., 2007; Wanke et al., 2008) .
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Supplemental Information includes three figures and three tables and can be found with this article online , partially protects TORC1 (quantified as in Figure 1D ) from inactivation during leucine starvation. Data are expressed as relative values with respect to the 0 time point and reported as averages (n = 3), with standard deviations indicated by the lines above each bar. (E) Model for the role of LeuRS Cdc60-mediated editing in Gtr1-TORC1 signaling. Nc-AA, noncognate amino acid. For details see text. See also Figure S3 .
